Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

Background. A 17-year-old white male with Crohn's disease who was receiving maintenance infusions of the anti-tumor necrosis factor (TNF) agent, infliximab, presented with a new-onset psoriasiform ...

This can cause what is known as tumor necrosis, where the tumor essentially dies from the inside out. More From Newsweek ...

Dr. Parsons believes that this tumor ablation is due to hemorrhagic necrosis of the tumor, as the compound EBC-46 destroys the more fragile capillaries that feed the tumor. In other words ...

Ultrasound of the liver shows a fluid-filled mass with a peripheral thin rim of viable tumor (arrows). This lesion was a necrotic metastasis from colon cancer. The irregular inner wall (open arrow ...

Nanjing Reju Therapeutics Inc. has described tumor necrosis factor receptor type 1-associated DEATH domain protein (TRADD) inhibitors reported to be useful for the treatment of inflammatory-related ...

reduction in metastatic colonies in lung tumor and decrease in necrotic regions in breast tumor. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to ...

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.